What is the evidence basis for NCCN bladder cancer guidelines?

Updated: Feb 23, 2021
  • Author: Kara N Babaian, MD, FACS; Chief Editor: Bradley Fields Schwartz, DO, FACS  more...
  • Print

NCCN - Recommendations are derived from critical evaluation of evidence, integrated with the clinical expertise and consensus of a multidisciplinary panel of cancer specialists, clinical experts and researchers in those situations where high-level evidence does not exist [1] ; all guideline recommendations are category 1 (supported by uniform consensus based on high-level evidence) or category 2A (uniform consensus based on lower-level evidence)

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!